# Fixture: Continuation turn — user picks Option A from a prior options memo

This fixture tests the Stage 3 → Stage 4 transition. The user has already received a Stage 2 options memo (from a prior turn in the same conversation) and is now responding with a selection. The skill should confirm the selected endeavor and run the full evaluation against it, without re-orienting or re-proposing options.

---

## Context the skill should know about (from the prior turn)

The skill previously produced a Stage 2 memo with three options for this same petitioner:

- **Option A** — Develop and publicly release a maintained open-source protein–ligand interaction prediction framework, with a published methods paper, and drive documented adoption by at least three independent U.S. academic drug-discovery groups within twelve months — measured by named adopter labs, downstream publications using the framework as their evaluation or modeling backbone, and letters from independent users at named institutions.
- **Option B** — Lead a named industry–academia collaboration applying the petitioner's protein–ligand prediction methods to a specific therapeutic target program at a named U.S. pharmaceutical company.
- **Option C** — Build and release a public benchmark dataset and standardized evaluation methodology for protein–ligand interaction prediction, with documented adoption by independent U.S. research groups.

The skill recommended Option A as the closest fit to the petitioner's existing record.

## Profile (same as the prior turn — included again for completeness)

I'm a postdoctoral research fellow at a major U.S. research university in the computational biology department. My research focuses on protein structure prediction and protein–ligand interaction modeling, particularly applying deep learning methods to drug discovery problems.

**Education**
- Ph.D., Computational Biology, [major U.S. R1 university], 2024.
- M.S., Computer Science, [foreign university], 2019.
- B.S., Biochemistry, [foreign university], 2017.

**Publications**
- 11 peer-reviewed publications in journals and conferences including *Nature Communications*, *Bioinformatics*, *NeurIPS Workshop on Machine Learning for Structural Biology*, and *Journal of Chemical Information and Modeling*. Total citations per Google Scholar: 187. I have not separated independent from self-citations.
- First author on 4 papers; middle author on 6 papers (all with my Ph.D. advisor as senior author or co-senior author); last author on 1 paper from my master's work.

**Funding**
- Listed as a "key personnel" on an active NIH R01 grant (PI: my postdoctoral advisor). The grant funds the broader research program in which my project is embedded. I am not the PI or co-PI.
- Received a one-year postdoctoral fellowship from a private foundation focused on early-career researchers in computational biology. The fellowship supports my salary; not a project grant.

**Recognition**
- Travel award for best poster at one specialty workshop.
- Invited to give one talk at a sister lab at another R1 university.

**Other**
- Reviewed two manuscripts for *Bioinformatics* (assigned by my advisor's editor contact).
- No patents.
- No industry deployments.
- No documented adoption of my code or methods by other groups, though I have released code on GitHub for two of my projects (no documented downstream usage I can point to).

**Recommenders I could realistically obtain letters from**
- My Ph.D. advisor (also a co-author on most of my work).
- My current postdoc advisor (PI on the NIH R01).
- Two professors I collaborated with on specific projects who are co-authors on papers with me.
- One pharmaceutical-industry scientist I worked with briefly during a summer collaboration.

## User's current-turn message

Let's go with **Option A**. Please run the full evaluation against this endeavor.
